Combined Short-Chain Fatty Acids Induce an Anti-Inflammatory and Anti-Chemotactic Secretory Profile from 3T3-L1 Adipocytes in Normoxic and Hypoxic Environmental Conditions
Open Access
- 24 July 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (15) , 6583
Abstract
Short-chain fatty acids (SCFAs), acetate, propionate, and butyrate, are typically produced in a 3:1:1 ratio, respectively, via microbial fermentation of non-digestible carbohydrates, and to a lesser degree, from undigested protein. The effects of individual SCFAs on adipocyte function have been described; however, the effects of SCFAs in combination on adipocyte function remain unknown. Mature 3T3-L1 adipocytes were treated with a 1 mM total dose of acetate, propionate, and butyrate combined in a 3:1:1 ratio, respectively, for 24 h ± lipopolysaccharide (LPS, 10 ng/mL) under both normoxic and hypoxic (via the addition of 100 µM cobalt chloride) environmental conditions. In both normoxic and hypoxic LPS-stimulated conditions, SCFAs increased the secretion of adiponectin and reduced the secretion of resistin, interleukin (IL)-6, monocyte chemoattractant protein (MCP)-1/C-C motif chemokine ligand (CCL)2, and RANTES/CCL5, in addition to reducing intracellular protein levels of activated (i.e., the ratio of phosphorylated-to-total) nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) p65 and signal transducer and activator of transcription 3 (STAT3) (p < 0.05). Additionally, SCFA treatment reduced leptin secretion only in LPS-stimulated normoxic environmental conditions compared to control (p < 0.05). In normoxic conditions, SCFA + LPS increased mRNA expression of genes involved in fat storage), fatty acid recycling, and lipolysis, whereas in hypoxic conditions, SCFA + LPS decreased mRNA expression of genes involved in fat storage and triglyceride synthesis (p < 0.05), indicating different effects of SCFAs on adipocyte metabolic function depending on hypoxia status. Collectively, combined SCFAs in a 3:1:1 ratio beneficially modify the adipocyte adipokine secretory profile under both normoxic and hypoxic environmental conditions.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (04943)
- Canada Foundation for Innovation (41734)
- Ontario Research Fund (ORF) Research Infrastructure (RI) Small Infrastructure Fund
- NSERC Graduate Scholarship
- Ontario Graduate Scholarship
This publication has 145 references indexed in Scilit:
- EPA/DHA but Not ALA Reduces Visceral Adiposity and Adipocyte Size in High Fat Diet‐Induced Obese Delta‐6 Desaturase Knockout MiceMolecular Nutrition & Food Research, 2024
- Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancerClinical and Experimental Medicine, 2023
- Leptin as a key regulator of the adipose organReviews in Endocrine and Metabolic Disorders, 2021
- Long‐Term β‐galacto‐oligosaccharides Supplementation Decreases the Development of Obesity and Insulin Resistance in Mice Fed a Western‐Type DietMolecular Nutrition & Food Research, 2020
- The use of cobalt chloride as a chemical hypoxia modelJournal of Applied Toxicology, 2018
- Short‐Chain Fatty Acids Enhance the Lipid Accumulation of 3T3‐L1 Cells by Modulating the Expression of Enzymes of Fatty Acid MetabolismLipids, 2018
- Resistant maltodextrin or fructooligosaccharides promotes GLP-1 production in male rats fed a high-fat and high-sucrose diet, and partially reduces energy intake and adiposityEuropean Journal of Nutrition, 2017
- Resistin derived from diabetic perivascular adipose tissue up‐regulates vascular expression of osteopontin via the AP‐1 signalling pathwayThe Journal of Pathology, 2013
- Fructooligosaccharides suppress high‐fat diet‐induced fat accumulation in C57BL/6J miceBioFactors, 2011
- Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytesPflügers Archiv - European Journal of Physiology, 2007